Similar Search Results

The evolution of drug initiation: from social networks to public markets

Caulkins, Jonathan P. - In: Optimization, dynamics, and economic analysis : essays …, (pp. 353-367). 2000

Persistent link: https://www.econbiz.de/10001497182

Why present-oriented societies undergo cycles of drug epidemics

Behrens, Doris; Caulkins, Jonathan P.; Tragler, Gernot; … - 1999

Persistent link: https://www.econbiz.de/10001430179

Why present-oriented societies undergo cycles of drug eqidemics

Behrens, Doris; Caulkins, Jonathan P.; Tragler, Gernot; … - In: Journal of economic dynamics & control 26 (2002) 6, pp. 919-936

Persistent link: https://www.econbiz.de/10001654017

Optimal control of interacting systems with DNSS property : the case of illicit drug use

Zeiler, Irmgard; Caulkins, Jonathan P.; Tragler, Gernot - In: Journal of economic behavior & organization : JEBO 78 (2011) 1/2, pp. 60-73

Persistent link: https://www.econbiz.de/10009259810

Mandatory minimum drug sentences : throwing away the key or the taxpayers' money?

Caulkins, Jonathan P. (contributor) - 1997

Persistent link: https://www.econbiz.de/10008729771

Can supply restrictions lower price? : Violence, drug dealing and positional advantage

Caulkins, Jonathan P. (contributor); … - In: Contributions to economic analysis & policy 5 (2006) 1, pp. 1-18

Persistent link: https://www.econbiz.de/10003305694

Modelling drug market supply disruptions : where do all the drugs not go?

Caulkins, Jonathan P.; Hao, Haijing - In: Journal of policy modeling : JPMOD ; a social science … 30 (2008) 2, pp. 251-270

Persistent link: https://www.econbiz.de/10003664055

Why the DEA STRIDE data are still useful for understanding drug markets

Arkes, Jeremy; Pacula, Rosalie Liccardo; Paddock, Susan M. - 2008

Persistent link: https://www.econbiz.de/10003747047

When in a drug epidemic should the policy objective switch from use reduction to harm reduction?

Caulkins, Jonathan P.; Feichtinger, Gustav; Tragler, Gernot - In: European journal of operational research : EJOR 201 (2010) 1, pp. 308-318

Persistent link: https://www.econbiz.de/10003975640

Why the DEA STRIDE Data are Still Useful for Understanding Drug Markets

Arkes, Jeremy - 2008

In 2001, use of the STRIDE data base for the purposes of analyzing drug prices and the impact of public policies on drug markets came under serious attack by the National Research Council (Manski et al., 2001; Horowitz, 2001). While some of the criticisms raised by the committee were valid, many of...

Persistent link: https://www.econbiz.de/10012464423